Trebor R. Lawton

Trebor Lawton is a seasoned professional in the biotechnology field, currently serving as Co-Founder at Abyssinia Biologics since June 2017, where focus lies on the preclinical development and commercialization of innovative anti-oligomeric Aβ monoclonal antibodies targeting Alzheimer's disease. Previously, Trebor founded Abyssinia Biotechnologies, leading research and development for an OTC screening device aimed at preventing tick-borne diseases and securing funding through Maine Technology Institute grant proposals. Experience includes a role as Laboratory Technician at Aliquot, LLC, specializing in monoclonal antibody development, as well as earlier positions at Niche Diagnostics and Beach Dawgs Hotdog Cart. Trebor holds a Bachelor's degree in Biological Sciences with a concentration in Cellular and Molecular Biology from Connecticut College.